SEPT11 targets RhoA in vitro, regulates cytoskeleton rearrangement and abnormal cell adhesion through ROCK1 and FAK signaling pathways, thereby promoting the invasion and migration of HCC. This evidence concerns the gene PTK2 and hepatocellular carcinoma.